Literature DB >> 8161788

Wild-type p53 gene expression induces granulocytic differentiation of HL-60 cells.

S Soddu1, G Blandino, G Citro, R Scardigli, G Piaggio, A Ferber, B Calabretta, A Sacchi.   

Abstract

Overexpression of wild-type p53 gene in malignant cell lines has been shown to inhibit cell proliferation in a number of cases. However, endogenous p53 protein seems to play little role in normal cell-cycle control as suggested by the normal development of p53 null mice, and by the low p53 protein levels expressed in most cell types. Recently, increased expression of endogenous p53 protein has been observed during the cellular response to DNA damage, as well as during differentiation of human hematopoietic cells. To study the role of the p53 gene in hematopoietic differentiation, we introduced the wild-type p53 gene or the temperature-sensitive p53(Val135) mutant into p53-deficient HL-60 promyelocytic leukemia cells. Morphological analysis, flow-cytometric determination of granulocytic or monocytic surface markers, and ability to reduce nitroblue tetrazolium (NBT) demonstrated that expression of exogenous wild-type p53 gene in HL-60 cells induces differentiation through the granulocytic pathway. Proliferation and cell-cycle analysis performed early after expression of wild-type p53 showed that induction of differentiation is not coupled with growth arrest, which suggests that p53 is involved in differentiation independently of its activity on the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8161788

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Regulation of ES cell differentiation by functional and conformational modulation of p53.

Authors:  K Sabapathy; M Klemm; R Jaenisch; E F Wagner
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

2.  Tumor suppressor protein p53 regulates megakaryocytic polyploidization and apoptosis.

Authors:  Peter G Fuhrken; Pani A Apostolidis; Stephan Lindsey; William M Miller; Eleftherios T Papoutsakis
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

3.  Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53.

Authors:  L Resnick-Silverman; S St Clair; M Maurer; K Zhao; J J Manfredi
Journal:  Genes Dev       Date:  1998-07-15       Impact factor: 11.361

4.  Cytokines inhibit p53-mediated apoptosis but not p53-mediated G1 arrest.

Authors:  Y Lin; S Benchimol
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

5.  Phospholipase D2 (PLD2) shortens the time required for myeloid leukemic cell differentiation: mechanism of action.

Authors:  Mauricio Di Fulvio; Kathleen Frondorf; Karen M Henkels; William C Grunwald; David Cool; Julian Gomez-Cambronero
Journal:  J Biol Chem       Date:  2011-11-17       Impact factor: 5.157

6.  p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer.

Authors:  Darjus F Tschaharganeh; Wen Xue; Diego F Calvisi; Matthias Evert; Tatyana V Michurina; Lukas E Dow; Ana Banito; Sarah F Katz; Edward R Kastenhuber; Susann Weissmueller; Chun-Hao Huang; Andre Lechel; Jesper B Andersen; David Capper; Lars Zender; Thomas Longerich; Grigori Enikolopov; Scott W Lowe
Journal:  Cell       Date:  2014-07-31       Impact factor: 41.582

7.  Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.

Authors:  D Del Bufalo; A Biroccio; S Soddu; N Laudonio; C D'Angelo; A Sacchi; G Zupi
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

8.  Wild-type p53 induces diverse effects in 32D cells expressing different oncogenes.

Authors:  S Soddu; G Blandino; R Scardigli; R Martinelli; M G Rizzo; M Crescenzi; A Sacchi
Journal:  Mol Cell Biol       Date:  1996-02       Impact factor: 4.272

9.  Benzene-induced hematopoietic neoplasms including myeloid leukemia in Trp53-deficient C57BL/6 and C3H/He mice.

Authors:  Yasushi Kawasaki; Yoko Hirabayashi; Toyozo Kaneko; Jun Kanno; Yukio Kodama; Yuuko Matsushima; Yukio Ogawa; Minoru Saitoh; Kiyoshi Sekita; Osayuki Uchida; Takashi Umemura; Byung-Il Yoon; Tohru Inoue
Journal:  Toxicol Sci       Date:  2009-05-28       Impact factor: 4.849

10.  The MDM-2 antagonist nutlin-3 promotes the maturation of acute myeloid leukemic blasts.

Authors:  Paola Secchiero; Carlotta Zerbinati; Elisabetta Melloni; Daniela Milani; Diana Campioni; Roberto Fadda; Mario Tiribelli; Giorgio Zauli
Journal:  Neoplasia       Date:  2007-10       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.